Roquette has announced its plans to take direct compression formulation to the next level with the launch of two new mannitol products at this year’s edition of CPHI. In addition, the company will demonstrate its commitment to unlocking healthier futures with a focus on patient centricity.
As a sponsor of this year’s conference program, visitors are invited to join Roquette experts for a number of exclusive presentations, highlighting topics including solutions to tackle medication non-adherence and optimization of drug delivery systems with the right high-quality excipients.
In-person from November 1 to 3
Unveiling the new standard in direct compression
Roquette invites attendees at CPHI to discover the potential of high quality mannitol-based products designed to unlock innovative application areas, like controlled release tablets, and optimize direct compression processes.
“As a leading global pharmaceutical excipients supplier, it’s important for us to continuously harness the power of innovation to support our customers’ evolving formulation needs,” comments Paul Smaltz, Vice President of Pharmaceutical Solutions at Roquette. “We’re delighted to bring two brand-new solutions to the market that will open up new development opportunities in the direct compression space. We’ve spent significant time understanding our customers’ pain points, as well as those of the wider industry, so we can bring these specialized products to fruition and help to solve some of the toughest drug delivery challenges.”
Putting patient needs in the spotlight
For oral formulations, taste, appearance, and smell have a direct impact on medication adherence. This not only limits patients from leading a healthy life, but also affects the commercial bottom line. Smaltz explains: “Drug adherence is a significant issue today, with medication non-adherence accounting for half of all treatment failures in the USA. That’s why we’re putting patient centricity in the spotlight – we believe the world needs access to more innovative drug delivery systems and applications that support patient compliance. Achieving this vision demands all of our participation and CPHI is the perfect platform through which to share this message.”
On November 3, Roquette will take center stage as part of the "Patient Centricity" track 5 –
- 11:20 - 12:10 - Nasser Syed, Head of Marketing, Roquette Pharma Solutions, alongside other industry experts, will participate in a roundtable exploring the latest news and insights on consumer health, including how the pharmaceutical industry can better engage patients in education and decision-making.
- 12:15 - 13:40 - Arnaud Verhaeghe, Head of Oral Dosage, Roquette Pharma Solutions, will then present the latest innovations addressing patient compliance and enhancing consumer experience.
Visit Roquette in Hall 8.0 at stand 80C90 to connect with the team and experience its cutting-edge solutions for the pharmaceutical market!
Online from September 28
Hailong Zhang, Analytical Research Manager, Applied Science at Roquette, is happy to deliver a webinar available on-demand:
- Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPBCD) Stability Comparative Study and their Monoclonal Antibody Stability Benefits
1. Prescient & Strategic Intelligence, Medication Adherence Market Research Report: By Product (Software Centric, Hardware Centric), Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology) - Global Industry Analysis and Growth Forecast to 2030, September 2020 (available here: https://www.psmarketresearch.com/market-analysis/medical-adherence).